C4X Discovery Holdings PLC Director/PDMR Share Purchases
09 April 2024 - 11:58AM
RNS Regulatory News
RNS Number : 8719J
C4X Discovery Holdings PLC
09 April 2024
C4X Discovery Holdings
plc
("C4XD", "C4X Discovery"
or the "Company")
Director/PDMR Share
Purchases
9 April
2024 - C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery
company, was informed on 8 April 2024 that Clive Dix, Executive
Chairman of the Company, purchased 485,320 ordinary shares of 0.01
pence each ("Ordinary Shares") in the Company at a price of 10.3
pence per share.
Following this purchase of shares,
Clive Dix has a beneficial interest in 2,071,809 Ordinary Shares,
representing approximately 0.82 per cent. of the Company's issued
share capital.
Further information on the purchases
is contained in the disclosure tables below.
Contacts
C4X Discovery
Holdings
|
|
Mo Noonan, Communications
|
+44 (0)787 6444977
|
|
|
Panmure Gordon
(UK) Limited (NOMAD and Broker)
|
|
Freddy Crossley, Emma Earl (Corporate
Finance)
|
+44 (0)20 7886 2500
|
Rupert Dearden (Corporate Broking)
|
|
|
|
C4X Discovery
Media - Consilium Strategic Communications
|
|
Mary-Jane Elliott, Chris Gardner
|
+44 (0)203 709 5700
|
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM:
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
a)
|
Name
|
Clive Dix
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Executive Chairman
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
C4X Discovery Holdings plc
|
b)
|
LEI
|
213800UHNL82E323O870
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Ordinary shares of £0.01
each
GB00BQQ2RV18
|
b)
|
Nature of the transaction
|
Purchase of Shares
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
10.3 pence
|
485,320
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
n/a
|
e)
|
Date of the transaction
|
8 April 2024
|
f)
|
Place of the transaction
|
London Stock Exchange
|
Notes to
Editors:
About C4X
Discovery
C4X Discovery (C4XD) is a pioneering Drug Discovery
company, combining scientific expertise with cutting-edge
technologies to efficiently deliver world‑leading medicines. We
have a highly valuable and differentiated approach to Drug
Discovery through our enhanced molecular design and patient
stratification capabilities, generating small molecule drug
candidates across multiple disease indications focused on
immuno-inflammation. We are advancing our internal portfolio which
ranges from early-stage target opportunities to late-stage Drug
Discovery programmes and we have two commercially partnered
programmes with Sanofi and AstraZeneca, and one clinical stage
candidate which has been acquired by Indivior.
For more information visit us at www.c4xdiscovery.com or follow us
on twitter @C4XDiscovery.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHQKCBPCBKKOQK
C4x Discovery (LSE:C4XD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
C4x Discovery (LSE:C4XD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024